Kirkland & Ellis acted for GL Capital. Slaughter and May advised China International Capital Corporation Hong Kong Securities Limited (CICC) as financial adviser. Silver Pegasus Investment...
GL Capital’s $1.13 Billion Privatisation of Sciclone Pharmaceuticals
CIMC Vehicles’ Buy-back and Delisting of its H Shares
Kirkland & Ellis is advising CIMC Vehicles (Group) Co., Ltd. in the transaction. CIMC Vehicles (Group) Co., Ltd. (HKSE: 1839; SZSE: 301039) announced its proposal to...
MoneyHero Group’s Business Combination with Bridgetown
Kirkland & Ellis advised MoneyHero Group, while Skadden, Arps, Slate, Meagher & Flom advised Bridgetown Holdings. CompareAsia Group Capital Limited (“MoneyHero” or the “Company”), a market...
Yitai Coal’s Buy-back and Delisting of H Shares
Kirkland & Ellis advised China International Capital Corporation Hong Kong Securities Limited (CICC) on the deal. Inner Mongolia Yitai Coal Co., Ltd. has announced its proposal to buy-back...
Gravitas Education Holdings’ Acquisition of eLMTree
Skadden is serving as U.S. legal counsel to a special committee of the board of directors of Gravitas, Cleary Gottlieb is serving as U.S. legal counsel to...
Wynn Macau’s $600 Million Convertible Bonds Offering
Kirkland & Ellis, Rato, Ling, Lei & Cortés and Maples and Calder are advising Wynn Macau, while Latham & Watkins is advising the initial purchasers, and...
Power Heritage Group’s HK$1.291 Billion Proposed Privatization of Jiangnan Group
Kirkland & Ellis advised Power Heritage Group Limited on the deal. The respective directors of Power Heritage Group Limited and Jiangnan Group jointly announced that on 16 February...
Bain Capital Private Equity’s $400 Million Equity Investment in EcoCeres
Kirkland & Ellis advised Bain Capital Private Equity on the deal. Bain Capital Private Equity announced its significant equity investment in EcoCeres. EcoCeres is incubated by The Hong...
SciClone Pharmaceuticals’ HK$780 Million Voluntary Share Buy-Back Offer
Kirkland & Ellis advised SciClone Pharmaceuticals on the offer. SciClone Pharmaceuticals (Holdings) Limited (HKSE: 6600) announced its HK$780 million voluntary conditional cash offer to buy-back up to...
Link REIT’s $1.6 Billion Acquisition of Portfolio of Assets in Singapore
Kirkland & Ellis advised Link REIT on the deal. Link REIT (HKSE: 823) announced its acquisition of a portfolio of assets in Singapore, including retail malls...
Skyworth Group’s HK$380 Million Share Buy-Back Offer
Kirkland & Ellis advised Skyworth Group Limited on the deal. Skyworth Group Limited (HKSE: 00751) announced its HK$380 million voluntary conditional cash offer to buy-back a...
Shenzhen EVOC Intelligence Technology Company Limited’s Privatization of EVOC Intelligent Technology Company Limited
Kirkland & Ellis advised China International Capital Corporation Hong Kong Securities Limited, as financial adviser to Shenzhen EVOC Intelligence Technology Company Limited. Shenzhen EVOC Intelligence Technology...